Former scientists and consultants doing trading and investing for side income. We like to develop and improvise rational frameworks to evaluating stocks and like looking for inefficiencies in the market. We like to identify the key value drivers and like developing easy to understand investment and trading strategies. See Seeking Alpha's policy on anonymous authors (http://seekingalpha.com/page/policy_anonymous_contributors).
The author is an independent investor. His value investing philosophy is based on the wisdom of value investing giants, using a systematic quantitative approach to identify stocks that carry asymmetric and positive risk/reward opportunity. The author provides opinions and information, but does not contain recommendations or personal investment advice to any specific person for any particular purpose. Do your own research or obtain suitable personal advice. You are responsible for your own investment decisions.
Armed with a doctorate in Neuroscience, reading about and actively investing is a deep interest of mine. Rather than preaching to more financially-qualified MBAs/CEOs/hedge fund managers, I want to raise interesting questions and state observations that I hope will draw some interest and debate into investment strategies and ultimately, improve my odds of becoming a billionaire!
StockMatusow.com Writers are:
Scott Matusow; Team Leader, owner and founder of StockMatusow.com.
Scott is an independent investor/writer/trader and team leader of StockMatusow.com.
He has have about fifteen years of stock market experience which include trading, investing, and managing his family’s trust as well as his personal account.
Scott has had the most success in trading/investing in smaller cap growth companies. Because Scott is not 'officially trained' in the markets, he see things 'outside the box.' Scott uses his ability to read situations and emotion, charts, times and sales, historical data, and macroeconomic and other market forces to predict stock price movements. Using these allowed for him to completely divest his own and family's money near the top of the market before the 2008 financial crisis.
Scott has his own online talk show which can be heard at www.scottmatusow.com/radio .
During market hours, we engage in talk about Stocks and Politics. After hours, Scott engages in a variety of talk issues from Poker, Sports, Politics, Current Events and whatever the chat room people wish to talk about.
Other places you can follow Scott are:
Kyle Dennis; writer, analyst, trader, website design, and team member of Stockmatusow.com.
Kyle has a Biology degree from the University of California Los Angeles (UCLA) and specializes in trading the biotechnology sector.
Kyle has extensive experience in researching, writing, and editing articles that have been published in scientific journals. He uses these experiences to write and comment about the potential of various biotechnology companies. Kyle specializes in evaluating trial success, drug potential, and market valuations.
As an investor/trader, Kyle likes to focus on chart analysis and investor/trader sentiment to identify good entry and exit points.
Kyle can also be followed at www.twitter.com/kylewdennis @kylewdennis
Michael Kovar; writer, editor, investor, trader and team member of stockmatusow.com
Michael has spent over ten years in financial roles with companies large and small. Recently, he spent time in a consulting role with Thomson Reuters legal headquarters in Eagan, MN. He currently works in an analyst position with a healthcare organization. Since 2011, Michael has worked with Scott Matusow to help research and edit articles for Stockmatusow.com.
Michael can be followed at www.twitter.com/MMK_3399 @MMK_3399
I have over twenty years experience on the buy side and sell side of the street. I have been an investor in all asset classes, including private companies in the technology and healthcare / life sciences sectors.
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
HAVE BEEN A MARKET INVESTOR AND TRADER SINCE THE AGE OF TWELVE....SPENT ABOUT 8 YEARS AS A BROKER , THEN ENDED UP IN THE FAMILY BUSINESS.....RAN THAT FOR THIRTY FIVE YEARS AND SOLD IT WHEN NONE OF THE KIDS WERE INTERESTED IN TAKING OVER....NEVER LOST MY PASSION FOR THE MKT AND INVESTED AND TRADED WHILE IN THE FAMILY BIZ...BECAME VERY INTERESTED IN THE TECH SIDE WHEN I WAS A BROKER AND TOOK THE WYCKOFF COURSE....HAVE USED IT TO PRIMARILY FIND VOLUME SURGES AND THEN GO FIND OUT WHY IT HAPPENED.....I AM MOSTLY A SUPPLY AND DEMAND PERSON......DON'T REALLY UNDERSTAND THE FANCY INDICATERS....AS WYCKOFF SAYS.....VOLUME AND PRICE ACTION TELL THE STORY....YOU JUST HAVE TO TRY AND UNDERSTRAND WHAT IT MEANS........TED